Latest Insider Transactions at Magenta Therapeutics, Inc. (MGTA)
This section provides a real-time view of insider transactions for Magenta Therapeutics, Inc. (MGTA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Magenta Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Magenta Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 27
2024
|
Fairmount Funds Management LLC Director |
SELL
Other acquisition or disposition
|
Indirect |
62,146
-100.0%
|
-
|
|
Apr 01
2024
|
Fairmount Funds Management LLC Director |
BUY
Other acquisition or disposition
|
Indirect |
58,857
+2.13%
|
-
|
|
Apr 01
2024
|
Fairmount Funds Management LLC Director |
SELL
Other acquisition or disposition
|
Indirect |
58,857
-100.0%
|
-
|
|
Jan 22
2024
|
Leon O Moulder Jr |
BUY
Grant, award, or other acquisition
|
Indirect |
166,667
+10.39%
|
$2,000,004
$12.0 P/Share
|
|
Jan 22
2024
|
Fairmount Funds Management LLC Director |
BUY
Grant, award, or other acquisition
|
Indirect |
834,334
+23.19%
|
$10,012,008
$12.0 P/Share
|
|
Jan 22
2024
|
Lei Meng |
BUY
Grant, award, or other acquisition
|
Indirect |
1,500,000
+35.57%
|
$18,000,000
$12.0 P/Share
|
|
Sep 29
2023
|
Fairmount Funds Management LLC Director |
BUY
Open market or private purchase
|
Indirect |
24,670
+1.26%
|
$320,710
$13.63 P/Share
|
|
Sep 26
2023
|
Fairmount Funds Management LLC Director |
BUY
Open market or private purchase
|
Indirect |
30,000
+1.55%
|
$390,000
$13.15 P/Share
|
|
Sep 22
2023
|
Simrat Randhawa CHIEF MEDICAL OFFICER |
BUY
Open market or private purchase
|
Direct |
2,000
+33.33%
|
$26,000
$13.2 P/Share
|
|
Sep 21
2023
|
Simrat Randhawa CHIEF MEDICAL OFFICER |
BUY
Open market or private purchase
|
Direct |
2,000
+50.0%
|
$26,000
$13.2 P/Share
|
|
Sep 19
2023
|
Fairmount Funds Management LLC Director |
BUY
Open market or private purchase
|
Indirect |
30,000
+1.58%
|
$390,000
$13.2 P/Share
|
|
Sep 13
2023
|
Fairmount Funds Management LLC Director |
BUY
Open market or private purchase
|
Indirect |
9,367
+0.51%
|
$103,037
$11.76 P/Share
|
|
Sep 12
2023
|
Fairmount Funds Management LLC Director |
BUY
Open market or private purchase
|
Indirect |
14,887
+0.81%
|
$148,870
$10.85 P/Share
|
|
Feb 08
2023
|
Third Rock Ventures Iv, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
1,500,000
-32.91%
|
$0
$0.82 P/Share
|
|
Feb 07
2023
|
Third Rock Ventures Iv, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
2,200,000
-32.55%
|
$0
$0.83 P/Share
|
|
Nov 30
2022
|
Kristen Stants Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+12.9%
|
$0
$0.94 P/Share
|
|
Nov 30
2022
|
Jason Gardner Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+1.01%
|
$0
$0.94 P/Share
|
|
Nov 30
2022
|
Caren Deardorf Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+13.18%
|
$0
$0.94 P/Share
|
|
Nov 30
2022
|
Stephen F. Mahoney Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+14.8%
|
$0
$0.94 P/Share
|
|
Nov 30
2022
|
Thomas W. Beetham Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+13.1%
|
$0
$0.94 P/Share
|
|
May 31
2022
|
Thomas W. Beetham Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+15.08%
|
$0
$0.99 P/Share
|
|
May 31
2022
|
Jason Gardner Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+1.02%
|
$0
$0.99 P/Share
|
|
May 31
2022
|
Caren Deardorf Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+15.18%
|
$0
$0.99 P/Share
|
|
May 31
2022
|
Kristen Stants Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+14.8%
|
$0
$0.99 P/Share
|
|
Sep 16
2021
|
David Wayne Nichols Chief Technical Officer |
SELL
Open market or private sale
|
Direct |
5,694
-28.47%
|
$34,164
$6.73 P/Share
|
|
Sep 16
2021
|
Lisa Olson Officer |
SELL
Open market or private sale
|
Direct |
5,736
-28.68%
|
$34,416
$6.73 P/Share
|
|
Sep 16
2021
|
Thomas W. Beetham Officer |
SELL
Open market or private sale
|
Direct |
6,103
-30.52%
|
$36,618
$6.73 P/Share
|
|
Sep 16
2021
|
Jason Gardner Director |
SELL
Open market or private sale
|
Direct |
14,340
-4.76%
|
$86,040
$6.73 P/Share
|
|
Sep 16
2021
|
Caren Deardorf Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
6,238
-31.19%
|
$37,428
$6.73 P/Share
|
|
Sep 16
2021
|
Stephen F. Mahoney Officer |
SELL
Open market or private sale
|
Direct |
5,736
-28.68%
|
$34,416
$6.73 P/Share
|
|
Sep 16
2021
|
Kristen Stants Chief People Officer |
SELL
Open market or private sale
|
Direct |
5,736
-28.68%
|
$34,416
$6.73 P/Share
|
|
Sep 14
2021
|
Thomas W. Beetham Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+50.0%
|
-
|
|
Sep 14
2021
|
David Wayne Nichols Chief Technical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+50.0%
|
-
|
|
Sep 14
2021
|
Jason Gardner Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+14.24%
|
-
|
|
Sep 14
2021
|
Stephen F. Mahoney Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+50.0%
|
-
|
|
Sep 14
2021
|
Caren Deardorf Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+50.0%
|
-
|
|
Sep 14
2021
|
Kristen Stants Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+50.0%
|
-
|
|
Sep 14
2021
|
Lisa Olson Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+50.0%
|
-
|
|
Aug 26
2021
|
Alexis Borisy Director |
BUY
Other acquisition or disposition
|
Direct |
4,100
+50.0%
|
-
|
|
Aug 25
2021
|
Third Rock Ventures Iv, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
1,250,000
-15.61%
|
-
|
|
Feb 11
2021
|
Atlas Venture Fund X, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
968,726
-23.53%
|
-
|
|
Jun 25
2018
|
Third Rock Ventures Iv, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
7,911,455
+49.7%
|
-
|
|
Jun 25
2018
|
Gv 2016 Gp, L.L.C. > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
3,339,137
+50.0%
|
-
|